Hyperpolypharmacy in patients with chronic kidney disease and its impact on clinical outcomes

A Agathe Mouheb M Marie Metzger N Natalia Alencar de Pinho C Christian Jacquelinet M Maurice Laville Z Ziad A. Massy S Sophie Liabeuf S Solène M. Laville D Dorothée Cannet C Christian Combe D Denis Fouque A Aghiles Hamroun Y Yves-Edouard Herpe O Oriane Lambert C Céline Lange P Pascal Morel C Christophe Pascal R Roberto Pecoits-Filho (Pontifícia Universidade Católica do Paraná, Curitiba, Brazil) J Joost Schantsra B Bénédicte Stengel T T. Hannedouche B B. Moulin A A. Klein C C. Combe J J. P. Bourdenx A A. Keller C C. Delclaux B B. Vendrely B B. Deroure A A. Lacraz T T. Lobbedez I I. Landru Z Z. Massy P P. Lang X X. Belenfant E E. Thervet P P. Urena M M. Delahousse C C. Vela M M. Essig D D. Clément H H. Sekhri M M. Smati M M. Jamali B B. Hacq V V. Panescu M M. Bellou L Luc Frimat N N. Kamar C C. Noël F F. Glowacki N N. Maisonneuve R R. Azar M M. Hoffmann (Google Research, Mountain View, CA, USA.) M M. Hourmant A A. Testa D D. Besnier G G. Choukroun G G. Lambrey S S. Burtey G G. Lebrun E E. Magnant M M. Laville D D. Fouque L L. Juillard C C. Chazot P P. Zaoui F F. Kuentz